Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease

Background. MoCA is widely used in Parkinson’s disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive def...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily J. Henderson, Howard Chu, Daisy M. Gaunt, Alan L. Whone, Yoav Ben-Shlomo, Veronica Lyell
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2016/1012847
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551310343274496
author Emily J. Henderson
Howard Chu
Daisy M. Gaunt
Alan L. Whone
Yoav Ben-Shlomo
Veronica Lyell
author_facet Emily J. Henderson
Howard Chu
Daisy M. Gaunt
Alan L. Whone
Yoav Ben-Shlomo
Veronica Lyell
author_sort Emily J. Henderson
collection DOAJ
description Background. MoCA is widely used in Parkinson’s disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive deficits on MoCA testing, (b) equivalent MoCA and TYM scores, and (c) interrater reliability in TYM testing. Methods. We assessed the discriminant ability of TYM and the equivalence between TYM and MoCA scores and measured the interrater reliability between three raters. Results. Of the 135 subjects that completed both tests, 55% had cognitive impairment according to MoCA. A MoCA score of 25 was equivalent to a TYM score of 43-44. The area under the receiver operator characteristic (ROC) curve for TYM to differentiate between PD-normal and PD-cognitive impairment was 0.82 (95% CI 0.75 to 0.89). The optimal cutoff to distinguish PD-cognitive impairment from PD-normal was ≤45 (sensitivity 90.5%, specificity 59%) thereby correctly classifying 76.3% of patients with PD-cognitive impairment. Interrater agreement was high (0.97) and TYM was completed in under 7 minutes (interquartile range 5.33 to 8.52 minutes). Conclusions. The TYM test is a useful and less resource intensive screening test for cognitive deficits in PD.
format Article
id doaj-art-37c791f36aba4dff9955fb15a718676b
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-37c791f36aba4dff9955fb15a718676b2025-02-03T06:01:43ZengWileyParkinson's Disease2090-80832042-00802016-01-01201610.1155/2016/10128471012847Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s DiseaseEmily J. Henderson0Howard Chu1Daisy M. Gaunt2Alan L. Whone3Yoav Ben-Shlomo4Veronica Lyell5School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKTaunton and Somerset NHS Foundation Trust, Musgrove Park Hospital, Parkfield Drive, Taunton, Somerset TA1 5DA, UKBristol Randomised Trials Collaboration, School of Social and Community Medicine, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKMovement Disorders Group, Bristol Brain Centre, Southmead Hospital, Bristol BS10 5NB, UKSchool of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKRoyal United Hospital NHS Foundation Trust, Combe Park, Bath BA1 3NG, UKBackground. MoCA is widely used in Parkinson’s disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive deficits on MoCA testing, (b) equivalent MoCA and TYM scores, and (c) interrater reliability in TYM testing. Methods. We assessed the discriminant ability of TYM and the equivalence between TYM and MoCA scores and measured the interrater reliability between three raters. Results. Of the 135 subjects that completed both tests, 55% had cognitive impairment according to MoCA. A MoCA score of 25 was equivalent to a TYM score of 43-44. The area under the receiver operator characteristic (ROC) curve for TYM to differentiate between PD-normal and PD-cognitive impairment was 0.82 (95% CI 0.75 to 0.89). The optimal cutoff to distinguish PD-cognitive impairment from PD-normal was ≤45 (sensitivity 90.5%, specificity 59%) thereby correctly classifying 76.3% of patients with PD-cognitive impairment. Interrater agreement was high (0.97) and TYM was completed in under 7 minutes (interquartile range 5.33 to 8.52 minutes). Conclusions. The TYM test is a useful and less resource intensive screening test for cognitive deficits in PD.http://dx.doi.org/10.1155/2016/1012847
spellingShingle Emily J. Henderson
Howard Chu
Daisy M. Gaunt
Alan L. Whone
Yoav Ben-Shlomo
Veronica Lyell
Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease
Parkinson's Disease
title Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease
title_full Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease
title_fullStr Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease
title_full_unstemmed Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease
title_short Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease
title_sort comparison of test your memory and montreal cognitive assessment measures in parkinson s disease
url http://dx.doi.org/10.1155/2016/1012847
work_keys_str_mv AT emilyjhenderson comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT howardchu comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT daisymgaunt comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT alanlwhone comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT yoavbenshlomo comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease
AT veronicalyell comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease